The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
NCT ID: NCT02275650
Last Updated: 2014-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2013-09-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maintenance of Vitamin D Level by UVB Radiation
NCT01101243
Comparing Different Amounts of Vitamin D Supplementation to Preschool Children Living in Northern and Southern Sweden
NCT01741324
Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels
NCT00910260
Does Sunbed Radiation With Mainly UVA Provoke Cutaneous Vitamin D Synthesis in Humans?
NCT00516867
Seasonal Variations in Serum 25-hydroxy Vitamin-D Levels in a Swedish Cohort
NCT02136407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
nbUVB
2 SED dose of nbUVB will be given every other week for this intervention group.
nbUVB
2 SED nbUVB exposure will be given every other week
control
No nbUVB illumination will be given for the control group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nbUVB
2 SED nbUVB exposure will be given every other week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fitzpacker's skin type II-IV
Exclusion Criteria
* diseases that inhibit vitamin D metabolism or absorption
* Fitzpacker's skin type I
* history of skin cancer
* vitamin D substitution 1 month before baseline or during study
* sun holidays 1 month before baseline or during study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Joint Authority for Päijät-Häme Social and Health Care
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Toni T Karppinen, MD
Role: PRINCIPAL_INVESTIGATOR
Päijät Häme Central Hospital
Erna Snellman, professor
Role: STUDY_DIRECTOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Päijät-Häme Central Hospital
Lahdenkylä, Pirkanmaa, Finland
Tampere University Hospital
Tampere, Pirkanmaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
maintenance_uv
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.